Countries World
The Nobel Assembly at the Karolinska Institutet has awarded the prestigious 2024 Nobel Prize in Physiology or Medicine to Dr. Victor Ambros and Dr. Gary Ru...
October 07, 2024 | News
Sanquin integrates Terumo BCT’s Reveos™ Automated Blood Processing System to enhance blood processing efficiency and increase production of e...
October 07, 2024 | News
Best-in-class, highly selective separations technology for the radiopharmaceuticals industry Exhibitor at the European Association of Nuclear Medicine (...
October 04, 2024 | News
Arcus and AstraZeneca to evaluate their respective molecules in combination to establish a potential first- and best-in-class treatment for clear c...
October 03, 2024 | News
First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...
October 03, 2024 | News
- SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in r...
October 02, 2024 | News
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis ...
October 01, 2024 | News
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RLS (USA) Inc. (RLS Radiopharmacies), the only Joint Commission-accredited radiopharmacy n...
September 23, 2024 | News
Unveiling Venue Sprint™, the latest Venue family solution offering maximum portability and advanced capabilities for high-quality scanning an...
September 20, 2024 | News
Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an invest...
September 18, 2024 | News
Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovati...
September 17, 2024 | News
Eli Lilly and Company (NYSE: LLY) announced the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 ...
September 16, 2024 | Analysis
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, announced a new milestone in t...
September 11, 2024 | News
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid t...
September 05, 2024 | News
Most Read
Bio Jobs
News
Editor Picks